lung cancer cell - Robuta Search

https://elifesciences.org/articles/64711 Persistent effects of pair bonding in lung cancer cell growth in monogamous Peromyscus californicus... Monogamous rodents of the genus Peromyscus, upon disruption of pair bonds, acquire increased oncogenic activity. lung cancer cell https://www.spandidos-publications.com/10.3892/or.2015.4057/abstract Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like... Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. lung cancer cell https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=38329&ver=9&handler=CreatePdf LCD - MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (L38329) Use this page to view details for the Local Coverage Determination for MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer. non small cell lung cancer https://www.mdpi.com/2072-6694/14/1/257 Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients With five-year survival rates as low as 3%, lung cancer is the most common cause of cancer-related mortality worldwide. The severity of the disease at... non small cell lung cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC4704273/ Impact of smoking on mortality of patients with non-small cell lung cancer - PMC Cigarette smoking is one of the major causes of lung cancer. However, the correlation between smoking status and the survival of patients with lung cancer is... non small cell lung cancer https://www.frontiersin.org/research-topics/53388/immunotherapy-in-small-cell-lung-cancer/magazine Immunotherapy in Small Cell Lung Cancer | Frontiers Research Topic Immunotherapy, and specifically immune checkpoint inhibitors (ICI), have transformed the landscape of cancer treatment over the past decade. Lung cancer is the... small cell lung cancer immunotherapy frontiers research topic https://www.businesswire.com/news/home/20251015335117/en/Eikon-Therapeutics-to-Present-New-Phase-2-Data-on-EIK1001-in-First-Line-Non-Small-Cell-Lung-Cancer-at-ESMO-2025 Eikon Therapeutics to Present New Phase 2 Data on EIK1001 in First-Line Non-Small Cell Lung Cancer... Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with cutting-edge laboratory and in s... https://www.preprints.org/manuscript/202310.0766 Mathematical Modeling of Non-small Cell Lung Cancer Biology Through the Experimental Data on Cell... Mathematical models of non-small cell lung cancer are powerful tools that use clinical and experimental data to describe various aspects of tumorigenesis. The... non small cell lung cancer https://medcraveonline.com/JCPCR/non-small-cell-lung-cancer-clinical-management-patterns-in-the-middle-east-and-north-africa-region.html Non-small cell lung cancer clinical management patterns in the Middle East and North Africa region... non small cell lung cancer https://clarivate.com/life-sciences-healthcare/report/acreon0014-2020-biopharma-non-small-cell-lung-cancer-access-and-reimbursement-us-2020/ Non-Small-Cell Lung Cancer | Access and Reimbursement | US | 2020 | Clarivate The high number of premium-priced non-small-cell lung cancer (NSCLC) therapies and the large number of NSCLC patients have resulted in a significant financial... non small cell lung cancer https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1503466/full Frontiers | The role of PSMC4 in non-small cell lung cancer: implications for prognosis, diagnosis,... IntroductionNon-small cell lung cancer (NSCLC) remains a principal cause of cancer-related mortality. The discovery of novel biomarkers is pivotal for enhanc... non small cell lung cancer https://www.cochrane.org/th/evidence/CD004699_surgery-may-improve-survival-rates-non-small-cell-lung-cancer-limited-lung-and-surrounding-affected Surgery may improve survival rates for non-small cell lung cancer limited to the lung and... non small cell lung cancer https://www.esmo.org/guidelines/clinical-practice-guideline-oncogene-addicted-metastatic-non-small-cell-lung-cancer Clinical Practice Guideline: Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer | ESMO non small cell lung cancer clinical practice guideline https://www.mskcc.org/research-programs/nci-small-cell-lung-cancer-consortium/research-projects NCI Small Cell Lung Cancer Consortium: Research Projects | Memorial Sloan Kettering Cancer Center The NCI Small Cell Lung Cancer (SCLC) Consortium is leading several research projects focused on understanding, screening for, and treating this disease. small cell lung cancer memorial sloan kettering https://www.mdpi.com/2072-6694/14/5/1181 Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2 Chemotherapy forms the backbone of current treatments for many patients with advanced non-small-cell lung cancer (NSCLC). However, the survival rate is low in... non small cell lung cancer https://www.spandidos-publications.com/10.3892/or.2016.4552/abstract Silencing NACK by siRNA inhibits tumorigenesis in non-small cell lung cancer via targeting Notch1... Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. non small cell lung cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC9553848/ circPTN Promotes the Progression of Non-Small Cell Lung Cancer through Upregulation of E2F2 by... Non-small cell lung cancer (NSCLC) is one of the most prevalent cancers, accounting for around 80% of total lung cancer cases worldwide. Exploring the function... non small cell lung cancer https://www.spandidos-publications.com/10.3892/or.2016.4587/abstract EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. lung cancer a549 cell egcg induces https://pmc.ncbi.nlm.nih.gov/articles/PMC10000454/ Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer... Surgery or conventional radical radiotherapy are established curative treatment options for patients with localised, stage I non-small-cell lung cancer... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-asa404-and-chemotherapy-for-non-small-cell-lung-cancer-that-has-spread A trial of ASA404 and chemotherapy for non small cell lung cancer that has spread (ATTRACT 1) This trial was looking at a drug called ASA404 in combination with paclitaxel and carboplatin for non small cell lung cancer (NSCLC) that was stage 3B or 4. https://www.preprints.org/manuscript/202507.2581 Utility and Future Perspectives of Circulating Tumor DNA Analysis in Non-small Cell Lung Cancer... Perioperative/neoadjuvant chemo-immunotherapy is a standard treatment for patients with resectable non-small cell lung cancer (NSCLC). However, several key... https://www.zupyak.com/p/1753794/t/non-small-cell-lung-cancer-market-analysis-market-share-market-research-report-leading-companies Non-Small Cell Lung Cancer Market Analysis, Market Share, Market Research Report, Leading Companies non small cell lung cancer market analysis https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-at-circulating-tumour-dna-for-non-small-cell-lung-cancer-lucid A study looking at circulating tumour DNA for non small cell lung cancer (LUCID) This study was done to find out more about small pieces of genetic material (DNA) that cancer cells can release into the bloodstream. non small cell lung cancer https://www.dukehealth.org/treatments/cancer/lung-cancer/small-cell-lung-cancer Small Cell Lung Cancer | Duke Health Duke oncologists who specialize in small cell lung cancer personalize your treatment based on your small cell lung cancer tumor biology. small cell lung cancer duke health https://www.mskcc.org/cancer-care/clinical-trials/24-026 A Phase 2 Study of Zipalertinib in People With Advanced Non-Small Cell Lung Cancer | Memorial Sloan... Full Title An Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients with Locally Advanced or... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-mri-scan-diagnose-non-small-cell-lung-cancer-streamline-l A study looking at an MRI scan to diagnose non small cell lung cancer (Streamline L) This study is looking to see if a whole body MRI scan may be able to replace a range of tests for diagnosing non small cell lung cancer. non small cell lung cancer https://www.pharmaceutical-technology.com/data-insights/mrt-2359-monte-rosa-therapeutics-small-cell-lung-cancer-likelihood-of-approval/ MRT-2359 by Monte Rosa Therapeutics for Small-Cell Lung Cancer: Likelihood of Approval Jun 14, 2024 - MRT-2359 is under clinical development by Monte Rosa Therapeutics and currently in Phase II for Small-Cell Lung Cancer. small cell lung cancer https://www.aacr.org/patients-caregivers/progress-against-cancer/immunotherapy-small-cell-lung-cancer-nivolumab-opdivo/ Expanding Immunotherapy to Small Cell Lung Cancer | The AACR Feb 4, 2020 - The FDA expanded the use of nivolumab to include treating certain patients with small cell lung cancer. Learn more about this FDA approval. small cell lung cancer expanding immunotherapy aacr https://elifesciences.org/articles/101885v1 Mechanistic insight for T-cell exclusion by cancer-associated fibroblasts in human lung cancer |... The crosstalk between cancerous lesions and the immune system in the lungs demonstrates the complex role of fibroblasts. cancer associated fibroblasts https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-adjuvant-treatment-non-small-cell-lung-cancer FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer | FDA On January 26, 2023, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) for adjuvant treatment following resection and... adjuvant treatment https://www.wikidata.org/wiki/Q53608198 Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines... non small cell lung cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC5876310/ Inhibitory Effect of Kurarinone on Growth of Human Non-small Cell Lung Cancer: An Experimental... Kurarinone, a flavonoid isolated from Sophora flavescens Aiton, has been reported to have significant antitumor activity. However, the cytotoxic activity of... non small cell lung cancer https://www.kcl.ac.uk/news/immune-cell-linked-to-better-lung-cancer-survival Immune cell linked to better lung cancer survival | King's College London High levels of a unique type of immune cell is linked to a greater chance of remaining cancer-free after surgery for patients with lung cancer. king s college immune cell linked to lung cancer https://clarivate.com/life-sciences-healthcare/report/concon0002-2019-biopharma-non-small-cell-lung-cancer-china-in-depth-china-2019/ Non-Small-Cell Lung Cancer | China In-Depth | China | 2019 | Clarivate MARKET OUTLOOK Non-small cell lung cancer (NSCLC) is one of the most commonly diagnosed cancers and the leading cause of cancer-related deaths in China. NSCLC... non small cell lung cancer in depth china 2019 clarivate https://www.cochrane.org/de/evidence/CD006157_pre-operative-chemotherapy-might-increase-survival-patients-non-small-cell-lung-cancer-when-compared The pre-operative chemotherapy might increase survival in patients with non-small cell lung cancer... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-nivolumab-relatlimab-chemotherapy-non-small-cell-lung-cancer-relativity1903 A trial looking at nivolumab, relatlimab and chemotherapy for non small cell lung cancer... This trial is looking at nivolumab, relatlimab and chemotherapy for non small cell lung cancer that has spread or come back. https://www.hmpgloballearningnetwork.com/site/onc/centers-excellence/non-small-cell-lung-cancer Non-Small Cell Lung Cancer Excellence Forum | Oncology The Non-Small Cell Lung Cancer Excellence Forum from Oncology offers relevant news and insights for medical professionals. non small cell lung cancer excellence forum oncology https://www.spandidos-publications.com/10.3892/ijo.2013.2003 Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological... International Journal of Oncology is an international journal devoted to oncology research and cancer treatment. non small cell lung cancer https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-rilvegostomig-datopotamab-deruxtecan-non-small-cell-lung-cancer-spread-tropion-lung10 A trial looking at rilvegostomig and datopotamab deruxtecan for non small cell lung cancer that has... This trial is looking at rilvegostomig on its own or with datopotamab deruxtecan for non small cell lung cancer. non small cell lung cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC5367375/ miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the... Increasing number of studies report that microRNAs play important roles in radiosensitization. miR-30a has been proved to perform many functions in the... non small cell lung cancer https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-mk-3475a-for-non-small-cell-lung-cancer-mk3475a-f84 A trial looking at MK-3475A for non small cell lung cancer (MK3475A-F84) This trial is comparing a new drug called MK-3475A with pembrolizumab for non small cell lung cancer (NSCLC). non small cell lung cancer https://www.mdanderson.org/newsroom/archived-news/parp-inhibitor-improves-overall-response-rates-in-small-cell-lung-cancer-patients.h00-159224934.html ARCHIVED: PARP inhibitor improves overall response rates in small cell lung cancer patients | UT MD... In a randomized, Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center, adding the PARP inhibitor veliparib to a standard... https://www.chestnet.org/guidelines-and-topic-collections/media-galleries/webinars/small-cell-the-forgotten-lung-cancer-extensive-stage Small Cell: The Forgotten Lung Cancer (Extensive Stage) | Webinar - American College of Chest... In this webinar, experts explore the latest advancements in extensive-stage small cell lung cancer, equipping clinicians with the knowledge to optimize patient... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-olaparib-small-cell-lung-cancer-stomp A trial looking at olaparib for small cell lung cancer (STOMP) This trial looked at having olaparib as a maintenance treatment Open a glossary item for people with small cell lung cancer (SCLC). small cell lung cancer looking at trial olaparib https://www.mayo.edu/research/clinical-trials/cls-20574439 Grid Radiation Therapy For The Treatment Of Stage IV Non-Small Cell Lung Cancer - Mayo Clinic Learn more about services at Mayo Clinic. non small cell lung cancer https://www.jci.org/articles/view/61492/pdf JCI - ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/conference-presentations/2022/molecular-reflex-testing-in-non-small-cell-lung-cancer--an-optimal-approach- Molecular Reflex Testing in Non-Small Cell Lung Cancer: An Optimal Approach? | Quest Diagnostics Poster presentation with the title "Molecular Reflex Testing in Non-Small Cell Lung Cancer: An Optimal Approach?" presented at the ASCO 2022 (American Society... non small cell lung cancer https://clarivate.com/life-sciences-healthcare/report/dlsfon0007-2016-biopharma-non-small-cell-lung-cancer-disease-landscape-and-forecast-g7-2016/ Non-Small-Cell Lung Cancer | Disease Landscape and Forecast | G7 | 2016 | Clarivate Biomarker- and histology-driven prescribing has become standard practice in the treatment of non-small-cell lung cancer (NSCLC). The treatment algorithms for... non small cell lung cancer https://clarivate.com/life-sciences-healthcare/report/unneon0041-2026-biopharma-non-small-cell-lung-cancer-unmet-need-unmet-need-metastatic-nsclc-without-driver-mutations-us/ Non-Small-Cell Lung Cancer - Unmet Need - Unmet Need - Metastatic NSCLC without driver mutations... First-line treatment for non-small-cell lung cancer (NSCLC) patients without driver mutations typically includes an immune checkpoint inhibitor, with or... non small cell lung cancer https://www.fredhutch.org/en/news/spotlight/2024/08/cell-free-dna-profiling-may-unlock-the-key-to-studying-small-cel.html Cell free DNA profiling may unlock the key to studying small cell lung cancer - Fred Hutch Aug 21, 2024 - Researchers develop a blood-DNA test to detect small cell lung cancer https://www.prnewswire.com/news-releases/alk-non-small-cell-lung-cancer-markets-forecast-to-2030---market-analysis-pipeline-epidemiology-drug-sales--shares-by-country-and-competition-301088420.html ALK Non-Small Cell Lung Cancer Markets, Forecast to 2030 - Market Analysis, Pipeline, Epidemiology,... /PRNewswire/ -- The "Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC)- Market Insights, Epidemiology and Market Forecast to 2030" drug... non small cell lung cancer https://www.mskcc.org/cancer-care/clinical-trials/25-074 Expanded Access to Neladalkib (NVL-655) for People with Non-Small Cell Lung Cancer | Memorial Sloan... Full Title Expanded Access Treatment of Neladalkib (NVL-655) in Patients with Advanced ALK+ NSCLC or Other ALK+ Solid Tumors Purpose Researchers are assessing... non small cell lung cancer https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1523743/full Frontiers | Advances in adjuvant therapy for operable N2 non-small cell lung cancer: a narrative... Non-small cell lung cancer (NSCLC) is still the disease with the highest incidence rate among malignant tumors, in which NSCLC under N2 stage has obvious sur... non small cell lung cancer https://www.spandidos-publications.com/or/31/1/391 DNA crosslinks, DNA damage and repair in peripheral blood lymphocytes of non-small cell lung cancer... Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2017.00197/full Frontiers | Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body... The current standard of care for locally-advanced non-small cell lung cancer includes radiation, chemotherapy, and surgery in certain individualized cases. I... non small cell lung cancer https://www.hmpgloballearningnetwork.com/site/onc/videos/targeting-her2-exon-20-mutations-advanced-non-small-cell-lung-cancer Treating HER2-Mutated Advanced Non-Small Cell Lung Cancer Kelsey Pan, MD, presents a case of metastatic non-small cell lung cancer with a HER2 exon 20 mutation and extensive brain metastases, highlighting second-line... small cell treating her2 mutated advanced https://www.researchandmarkets.com/reports/5303629/non-small-cell-lung-cancer-nsclc Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Global Strategic Business Report The Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market, valued at USD 32.8B in 2024, is projected to reach USD 54B by 2030, growing at a 8.7% CAGR. non small cell lung cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-sevabertinib-non-squamous-non-small-cell-lung-cancer FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer | FDA On November 19, 2025, the Food and Drug Administration granted accelerated approval to sevabertinib. https://pmc.ncbi.nlm.nih.gov/articles/PMC8082063/ The Expression of Three Negative Co-Stimulatory B7 Family Molecules in Small Cell Lung Cancer and... In recent years, immune checkpoint inhibitors have shown significant effects in a variety of solid tumors. However, due to the low incidence of small cell lung...